Yuvraj_pawp, Author at Pharma Advancement

Gencia LLC and Takeda Pharmaceutical Company Limited announced today a partnership to develop a new class of small molecule drugs...

More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program;

by Yuvraj_pawp

5th October 2015

Takeda Pharmaceutical Company Limited (TSE: 4502) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (collectively “Takeda”), today announced that more...

Takeda joins WIPO Re:Search to Accelerate R&D of New Drugs For Neglected Tropical Diseases, Malaria and TB

by Yuvraj_pawp

5th October 2015

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced its participation in WIPO Re:Search, a consortium to accelerate research and development...

Asthma: U.S. FDA approves new indication for SPIRIVA® Respimat®

by Yuvraj_pawp

5th October 2015

U.S. FDA latest regulatory authority to approve SPIRIVA® (tiotropium) Respimat® in asthma1 following authorities in the EU, Japan and other...

Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

by Yuvraj_pawp

5th October 2015

Jardiance® achieved superiority for the primary CV endpoint and a significant reduction in CV death in people with T2D at...

Boehringer Ingelheim and BioMed X apply crowdsourcing to establish a team of scientists for identifying key epigenetic regulators of COPD

by Yuvraj_pawp

5th October 2015

• Aims to identify novel epigenetic drivers to find new approaches for treating COPD• Crowdsourcing used to find unconventional solutions...

ERS 2015: Landmark year for Boehringer Ingelheim’s respiratory portfolio – new data for COPD, IPF and asthma treatments

by Yuvraj_pawp

5th October 2015

Head-to-head ENERGITO® study comparing benefits of Spiolto® Respimat® to LABA/ICS therapy in COPD1 and sub-analysis of OTEMTO® 1&2 trials showing...

Boehringer Ingelheim Animal Health launches two new swine vaccines in Europe

by Yuvraj_pawp

5th October 2015

New vaccines Ingelvac PRRSFLEX® EU for piglets and ReproCyc® PRRS EU for sows offer sustainable control of Porcine Reproductive and...

US FDA grants breakthrough therapy designation for Roche’s investigational medicine ACE910 for people with haemophilia A with factor VIII inhibitors

by Yuvraj_pawp

5th October 2015

First factor VIIIa-mimetic bispecific antibody to be investigated for the prophylactic treatment of haemophilia A Ninth breakthrough therapy designation for Roche’s...

For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices

by Yuvraj_pawp

5th October 2015

For the seventh consecutive year, Roche (SIX: RO, ROG; OTCQX: RHHBY) has been recognised as the Group Leader in sustainability...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Yuvraj_pawp

Gencia and Takeda Team to Discover and Develop Novel Class of Mitochondrial Therapeutics

More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program;

Takeda joins WIPO Re:Search to Accelerate R&D of New Drugs For Neglected Tropical Diseases, Malaria and TB

Asthma: U.S. FDA approves new indication for SPIRIVA® Respimat®

Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Boehringer Ingelheim and BioMed X apply crowdsourcing to establish a team of scientists for identifying key epigenetic regulators of COPD

ERS 2015: Landmark year for Boehringer Ingelheim’s respiratory portfolio – new data for COPD, IPF and asthma treatments

Boehringer Ingelheim Animal Health launches two new swine vaccines in Europe

US FDA grants breakthrough therapy designation for Roche’s investigational medicine ACE910 for people with haemophilia A with factor VIII inhibitors

For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password